CNGA3 and achromatopsia: Our approach is specifically tailored to compliment clinical genomics in determining pathogenicity in CNGA3-associated achromatopsia, but future perspectives include extrapolation to non-Mendelian disorders with coding variants and prominent effects on a functional protein level.